NEW YORK (GenomeWeb News) – Oxford Gene Technology has licensed the rights to make and market certain oligonucleotide microarrays using the company’s Southern array patents to BF-BIOlabs, OGT said today.
 
Under the license, BF-BIOlabs will be able to sell arrays and array-based services for identifying genes, SNPs, and gene expression analysis.
 
OGT said the license will remain valid for the lifetime of the patents. Financial terms of the agreement were not released.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.